glp-1 in type 1 diabetes patients with residual ß-cell function, treatment Frontiers | GLP-1R in diabetes
Description
Short-term prediction of glucose in type 1 diabetes using kernel adaptive filters
Backed by 3 powerful mechanisms: GLP-1 Core Act
A number of major limitations are worth mentioning
In non-diabetic conditions, pancreatic alpha cells mainly produce glucagon, which is a counter-regulatory hormone to insulin, so that homeostasis of glucose metabolism is maintained
Of the patients who took semaglutide and then developed NAION, those aged 40 to 64 (HR=3.31), who were female (HR=3.24), who were white (HR=2.34) or who had hypertension (HR=2.42) were more likely to be affected
